KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Aims to build the largest connected healthcare ecosystem in India
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Subscribe To Our Newsletter & Stay Updated
